AR027540A1 - USE OF MICX PROTEIN TOXOPLASMA GONDII OR ONE OF ITS DERIVATIVES AS AN IMMUNOGEN AGENT OR AS A VACCINATION ANTIGEN - Google Patents

USE OF MICX PROTEIN TOXOPLASMA GONDII OR ONE OF ITS DERIVATIVES AS AN IMMUNOGEN AGENT OR AS A VACCINATION ANTIGEN

Info

Publication number
AR027540A1
AR027540A1 ARP010100825A ARP010100825A AR027540A1 AR 027540 A1 AR027540 A1 AR 027540A1 AR P010100825 A ARP010100825 A AR P010100825A AR P010100825 A ARP010100825 A AR P010100825A AR 027540 A1 AR027540 A1 AR 027540A1
Authority
AR
Argentina
Prior art keywords
derivatives
protein
micx
toxoplasma gondii
vaccination antigen
Prior art date
Application number
ARP010100825A
Other languages
Spanish (es)
Original Assignee
Virsol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virsol filed Critical Virsol
Publication of AR027540A1 publication Critical patent/AR027540A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Utilizacion de la proteína MIC3 de Toxoplasma gonddi y/o de uno de sus derivados como agente inmunogeno o como antígeno de vacunacion.Use of the Toxoplasma gonddi MIC3 protein and / or one of its derivatives as an immunogenic agent or as a vaccination antigen.

ARP010100825A 2000-02-25 2001-02-23 USE OF MICX PROTEIN TOXOPLASMA GONDII OR ONE OF ITS DERIVATIVES AS AN IMMUNOGEN AGENT OR AS A VACCINATION ANTIGEN AR027540A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0002390A FR2805466A1 (en) 2000-02-25 2000-02-25 USE OF MIC3 PROTEIN FROM TOXOPLASMA GONDII OR ONE OF ITS DERIVATIVES AS AN IMMUNOGENIC AGENT OR AS A VACCINATION ANTIGEN

Publications (1)

Publication Number Publication Date
AR027540A1 true AR027540A1 (en) 2003-04-02

Family

ID=8847404

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100825A AR027540A1 (en) 2000-02-25 2001-02-23 USE OF MICX PROTEIN TOXOPLASMA GONDII OR ONE OF ITS DERIVATIVES AS AN IMMUNOGEN AGENT OR AS A VACCINATION ANTIGEN

Country Status (4)

Country Link
AR (1) AR027540A1 (en)
AU (1) AU2001235740A1 (en)
FR (1) FR2805466A1 (en)
WO (1) WO2001064243A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864966B1 (en) * 2004-01-13 2006-05-05 Agronomique Inst Nat Rech VACCINE STRAINS OF APICOMPLEXES OF THE SARCOCYSTIDAE FAMILY.
MX2007009524A (en) 2005-03-08 2008-03-04 Kenton S R L Chimeric recombinant antigens of toxoplasma gondii.
CA3042718A1 (en) * 2016-11-03 2018-05-11 Washington University Antigens for detecting toxoplasma infection by monitoring cellular immunity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2333598C (en) * 1998-05-28 2009-10-13 Abbott Laboratories Toxoplasma gondii antigens, p35, and uses thereof

Also Published As

Publication number Publication date
WO2001064243A2 (en) 2001-09-07
WO2001064243A3 (en) 2002-02-14
AU2001235740A1 (en) 2001-09-12
FR2805466A1 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
ATE264863T1 (en) 28-EPIRAPALOGUE
DE60118550D1 (en) NEUROTOXIN IMPLANT
DE60124863D1 (en) AGAINST HUMAN INTERLEUKIN-1-BETA RECOMBINANT ANTIBODIES
CY2009014I2 (en) VACCINE AGAINST BACTERIAL ANTIGENS
ATE233524T1 (en) MEDICAL BANDAGE
ATE367171T1 (en) BIOMEDICAL MOLDINGS
ITRM20020264A0 (en) ABSORBENT ARTICLE AND PROCEDURE FOR ITS MANUFACTURE.
TR200300478T2 (en) Humanized antiLT-ß-R antibodies
DE50111900D1 (en) MEDICAL IMPLANT
DK1284764T3 (en) Medical device
ATE270707T1 (en) ENTEPNEUMOVIRUS AND CORRESPONDING VACCINE
DK1334704T3 (en) Body prosthetic device
FR2815535B1 (en) PEDICULAR IMPLANT
ATE511855T1 (en) ADJUVANT FORMULATION FOR PUMULAR APPLICATION
NO20031860L (en) Kahalalid F
AR036844A1 (en) A SOFT ABSORBENT TISU CONTAINING DERIVATIZED AMINO-FUNCTIONAL POLYSYLOXANS.
BR9812976A (en) Neospora vaccine
ES2187796T3 (en) PEPTIDES REAGENT THAT ALLOW THE DETECTION OF HUMAN CITOMEGALOVIRUS (CMV).
AR036843A1 (en) A SOFT ABSORBENT TISU CONTAINING DERIVATIZED AMINO-FUNCTIONAL POLYSYLOXANS.
AR027540A1 (en) USE OF MICX PROTEIN TOXOPLASMA GONDII OR ONE OF ITS DERIVATIVES AS AN IMMUNOGEN AGENT OR AS A VACCINATION ANTIGEN
DE10193450D2 (en) Earplugs
IT1320834B1 (en) IMPLANT DEVICE FOR DENTAL PROSTHESES.
NO20021680L (en) Improved writing prosthesis
GB9810084D0 (en) Proteins
DK1027895T3 (en) Erysipelothrix rhusiopathiae antigens and vaccine preparations

Legal Events

Date Code Title Description
FB Suspension of granting procedure